|12:05 PM - 12:45 PM||
Opportunities and Challenges Using AI in unlocking the ADME Tox Obstacles in Drug Development
This session will address how machine and active learning are being applied to solve complex and difficult ADME Tox problems facing the pharma industry. There will be representation from both in-house and external models as well as pro and con viewpoints on applying AI to the challenges of the ADME/tox field. Industry innovators and researchers share their efforts in solving these challenges which could be worth hundreds of millions to industry, accelerate drug discovery and be invaluable to patients.